Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families and the breast cancer community. Further information about Puma Biotechnology, Inc. may be found at www.pumabiotechnology.com.